Healthy Skepticism Library item: 6499
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: Journal Article
Lexchin J.
Re: the promotion of Baralgin (dipyrone/pitofenone/fenpiverinium)
1994 Jun;
Abstract:
In the Philippines Hoechst is marketing Baralgin, a combination of dipyrone/pitofenone/fenpiverinium, for the treatment of spasmodic pain. The scientific literature does not support this use.
Keywords:
*analysis/Philippines/developing countries/Baralgin/dipyrone/Hoechst/quality of information/safety & risk information/Medical Lobby for Appropriate Marketing/MaLAM/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES